Sweeney, C J <br/><br/>
A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium.  [electronic resource] 

 -  Cancer  Aug 1999 
 - 514-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0142(19990801)86:3<514::aid-cncr21>3.0.co;2-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Transitional Cell--drug therapy<br/>Drug Administration Schedule<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Male<br/>Middle Aged<br/>Paclitaxel--administration & dosage<br/>Survival Analysis<br/>Urologic Neoplasms--drug therapy<br/>Urothelium